| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 12.031 | 17.906 | 18.008 | 13.498 | 19.140 |
| Total Income - EUR | - | - | - | - | 0 | 12.036 | 18.071 | 18.010 | 415.088 | 144.023 |
| Total Expenses - EUR | - | - | - | - | 28 | 10.334 | 9.249 | 29.470 | 270.823 | 154.273 |
| Gross Profit/Loss - EUR | - | - | - | - | -28 | 1.701 | 8.822 | -11.460 | 144.265 | -10.250 |
| Net Profit/Loss - EUR | - | - | - | - | -28 | 1.358 | 8.345 | -11.911 | 140.114 | -13.151 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Innovagen Co S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 27 | 275.230 | 283.122 | 270.948 | 252.183 | 512.059 |
| Current Assets | - | - | - | - | 51 | 42.145 | 35.571 | 36.422 | 232.410 | 30.460 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 687 | 18.468 | 12.478 | 26.365 | 28.959 |
| Cash | - | - | - | - | 51 | 41.459 | 17.103 | 23.944 | 206.045 | 1.501 |
| Shareholders Funds | - | - | - | - | 15 | 1.373 | 9.687 | -2.193 | 137.928 | 124.007 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 63 | 316.002 | 309.006 | 309.563 | 346.664 | 418.512 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Innovagen Co S.r.l.